Metraipolis › archive › dc_776efe80a95d
Efficacy and tolerability of mogamulizumab in mycosis fungoides and Sézary Syndrome: a monocentric retrospective study — Europe PMC PMID:41658563
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41658563
- DOI
- 10.3389/fonc.2025.1748746
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T13:48:38.587Z
- SHA-256 of the archived text
79ba9b20f6794945012a2c6a4f86e96d69e0a9ba00da262b2e66c17d57506c02- Stable URL of this page
https://metraipolis.com/documento/dc_776efe80a95d
How to cite
Efficacy and tolerability of mogamulizumab in mycosis fungoides and Sézary Syndrome: a monocentric retrospective study — Europe PMC PMID:41658563 — Europe PMC (en), https://europepmc.org/article/MED/41658563 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_776efe80a95d (Metraipolis archive dc_776efe80a95d, sha256 79ba9b20f6794945012a2c6a4f86e96d69e0a9ba00da262b2e66c17d57506c02)
BibTeX
@misc{dc776efe80a95d,
title = {Efficacy and tolerability of mogamulizumab in mycosis fungoides and Sézary Syndrome: a monocentric retrospective study — Europe PMC PMID:41658563},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41658563},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_776efe80a95d; sha256 79ba9b20f6794945012a2c6a4f86e96d69e0a9ba00da262b2e66c17d57506c02},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41658563. Agents can read the archived copy with the MCP tool read_document.